p73 poses a barrier to malignant transformation by limiting anchorage-independent growth

Michaela Beitzinger1, Lars Hofmann, Claudia Oswald

  • 1Molecular Tumor Biology Group, Rudolf-Virchow-Center, University of Würzburg, Würzburg, Germany.

The EMBO Journal
|February 2, 2008
PubMed

Insights

The p73 protein isoform TAp73 acts as a tumor suppressor by preventing anchorage-independent growth. Oncogenic Ras proteins reduce TAp73 levels, promoting cancer development.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The tumor suppressor protein p53 prevents cancer by controlling damaged cells.
  • The function of the p53 family member p73 in tumor suppression is not well understood.

Purpose of the Study:

  • To investigate the role of p73 in preventing tumor formation during premalignant stages.
  • To identify the mechanisms by which p73 suppresses cancer hallmarks.

Main Methods:

  • Utilized a step-wise transformation protocol in human cells.
  • Analyzed gene expression changes in response to pRB pathway alterations.
  • Investigated the transcriptional targets of TAp73, including KCNK1.
  • Examined the effect of oncogenic Ras on p73 isoform expression via phosphatidyl-inositol 3-kinase signaling.

Main Results:

  • TAp73 expression is induced during premalignant stages due to pRB pathway alterations.
  • TAp73 increases sensitivity to chemotherapy and oxidative stress, inhibiting proliferation and survival.
  • TAp73 activates KCNK1, a suppressor of anchorage-independent growth, which is downregulated in several cancers.
  • Oncogenic Ras shifts p73 expression from TAp73 to deltaNp73 in a PI3K-dependent manner.

Conclusions:

  • TAp73 functions as a critical barrier against anchorage-independent growth, a key cancer hallmark.
  • Downregulation of TAp73 by oncogenic Ras is a significant mechanism in tumor transformation.
  • TAp73 and its target KCNK1 represent potential therapeutic targets for cancers with altered p73 signaling.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...